CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 156 enrolled
Drug / intervention
ZuraPrep Clear Solution +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03782103
NCT03782103Phase 3Completed

Clinical Evaluation of the Antimicrobial Effectiveness of Topically Applied ZuraPrep

Zurex Pharma, Inc.·interventional·Posted Dec 20, 2018·Updated Feb 8, 2023

In Brief

A Phase 3 clinical trial evaluating ZuraPrep Clear Solution, ChloraPrep, and 1 other intervention for Surgical Skin Preparation. Completed, enrolled 156 participants across 1 site.

Detailed Summary

The objective of the study is to demonstrate the antimicrobial efficacy of the Zurex Preoperative Prep (ZuraPrep - clear) on skin flora of the abdomen and inguinal regions of human subjects.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
20192020202120222023202420252026
First PostedDec 20, 2018
Enrollment StartJan 25, 2019
Primary CompletionMay 12, 2019
Study CompletionSep 26, 2019
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 7.5 years ago

Interventions

ZuraPrep Clear Solutiondrug

Apply topically.

ChloraPrepdrug

Apply topically.

ZuraPrep Vehicledrug

Apply topically.